Rybelsus

Rybelsus – is the brand name for oral semaglutide, which is the first GLP-1 receptor agonist in a pill form. It is prescribed to improve blood sugar control in adults with type 2 diabetes, and it may also be used for chronic weight management in adults with obesity or who are overweight and have weight-related complications. As with any medication, it's important to consult with a healthcare professional before starting or stopping the use of Rybelsus.